Targeting anti-HIV drugs to the CNS.
Targeting anti-HIV drugs to the CNS.
复制标题
DOI:
10.1517/17425240903081705
复制
发表时间:
2009-08
影响因子:
6.6
通讯作者:
Labhasetwar V
中科院分区:
文献类型:
--
作者:
Rao KS;Ghorpade A;Labhasetwar V
The development of antiretroviral drugs over the past couple of decades has been commendable due to the identification of several new targets within the overall Human Immunodeficiency Virus (HIV) replication cycle. However, complete control over HIV/Acquired Immune Deficiency Syndrome is yet to be achieved. This is because the current anti-HIV drugs, although effective in reducing plasma viral levels, cannot eradicate the virus completely from the body. This occurs because most anti-HIV drugs do not accumulate in certain cellular and anatomical reservoirs including the Central Nervous System (CNS). Insufficient delivery of anti-HIV drugs to the CNS is attributed to their low permeability across the blood-brain-barrier (BBB). Hence, low and sustained viral replication within the CNS continues even during prolonged antiretroviral drug therapy. Therefore, developing novel approaches that are targeted at enhancing the CNS delivery of anti-HIV drugs are required. In this review, we discussed the potential of nanocarriers and the role of cell-penetrating peptides in enhancing drug delivery to the CNS. Such drug delivery approaches could also lead to higher drug delivery to other cellular and anatomical reservoirs where the virus harbor than with conventional treatment, thus providing an effective therapy to eliminate the virus completely from the body.
登录
查看更多内容
影响因子:
3.7
作者:
Coloma, MJ;Lee, HJ;Pardridge, WM
通讯作者:
Pardridge, WM
影响因子:
4.6
作者:
Bocedi, A;Notaril, S;Ascenzi, P
通讯作者:
Ascenzi, P
影响因子:
12.7
作者:
An, SF;Groves, M;Scaravilli, F
通讯作者:
Scaravilli, F
影响因子:
3.9
作者:
Alyautdin, RN;Tezikov, EB;Kreuter, J
通讯作者:
Kreuter, J
影响因子:
4.8
作者:
Derossi, D;Calvet, S;Prochiantz, A
通讯作者:
Prochiantz, A